Isabel Ribes

Isabel Ribes

Auto-generated profile, based on publicly available information

Isabel Ribes

Internal Medicine Department, Alicante General University Hospital - Alicante Institute of Sanitary and Biomedical Research (ISABIAL), Alicante, Spain

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2022 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
OMOscar Moreno-Perez
Oscar Moreno-Perez
IRIsabel Ribes
Isabel Ribes
Vicente BoixVicente Boix
Vicente Boix
MMMaría Ángeles Martinez-García
María Ángeles Martinez-García
SOSilvia Otero-Rodriguez
Silvia Otero-Rodriguez
EMEsperanza Merino
Esperanza Merino
To describe breakthrough COVID-19 infection in patients who needed hospitalization and the factors associated with poor outcomes. We conducted a retrospective study on patients hospitalized with COVID-19 between December 27, 2020, and October 17, 2021, with either a complete vaccination (CV) scheme (diagnosed 2 weeks after the second dose of the Pfizer/Moderna/AstraZeneca or first dose of the Janssen vaccine was administered) or a partial vaccination (PV) scheme. The main outcomes were all-cause mortality and the need for invasive mechanical ventilation (IMV). The baseline factors associated with the outcomes were analyzed by multiple logistic regression to estimate the odds ratios (odds ratio [OR]; 95% confidence interval [CI]). A total of 145 (101 CV) patients were included. The CV subgroup was mainly composed of older males with high comorbidity (Charlson Index ≥3, 72%; immunosuppression, 20%) and with bilateral pneumonia in 63.4%. Limited therapeutic effort (LTE) was agreed upon for 28% of the patients. In the CV subgroup, endotracheal intubation was required in 10.9% of patients, reaching 15.3% when excluding LTE patients; the global mortality was 22.8%, reaching 41.4% in the subgroup with LTE. Although the patients with PV were younger and had fewer comorbidities, the main outcomes did not differ significantly between the CV and PV groups. The predictors of poor outcomes were age ≥ 65 years, confusion, ferritin > 500 mg/L, extensive lung infiltrates, and a Charlson Index ≥ 3. Patients with CV hospitalized because of breakthrough COVID-19 infection tend to be older persons, with comorbidities, and have a high mortality.

1 January 2021 in Current HIV Research
Verified
Journal Article
Closed access
PDF file
IRIsabel Ribes
Isabel Ribes
SRSergio Reus
Sergio Reus
SASantos Asensio
Santos Asensio
MGMar García-Ródenas
Mar García-Ródenas
RLRafael León
Rafael León
JPJoaquín Portilla
Joaquín Portilla
Background: Although the association between HIV infection and airways obstruction is well known, its etiopathogenesis is not clear. Objectives: Our aim was to analyze the association between biomarkers of systemic inflammation and bacterial translocation and pulmonary function tests in HIV infected patients and compare it between smokers and non-smokers. Methods: Cross-sectional, observational study. Inclusion criteria: people living with HIV with undetectable plasma viral load. Exclusion criteria: other comorbidities associated with systemic inflammation. Outcome variables: spirometry and diffusing capacity for carbon monoxide; explanatory variables: inflammatory biomarkers (interleukin-6, tumor necrosis factor-alpha), bacterial trans location (soluble CD14 [sCD14] and bacterial 16S rDNA), and variables related to HIV infection. Associations were tested using the Pearson/Spearman correlation tests, the student t test, and multi variable linear regression. Results: We included 71 patients (54.9% smokers). We did not observe significant differences in pulmonary function tests according to biomarkers of inflammation or bacterial translocation. In non-smokers (n=32), sCD14 was negatively correlated with forced expiratory volume in 1 second (R =-0.35, P = 0.048) and forced vital capacity (R=-0.40, P=0.023). Age, time since HIV diagnosis and CD4+ nadir were associated with alterations in PFTs. In smokers, the only association observed was between the pack-years and pulmonary obstruction. Conclusions: In non-smokers HIV patients, lung dysfunction can be, at least partially, related to bacterial translocation (sCD14), CD4+ nadir and time since HIV diagnosis.

5 November 2026 in Journal of Infection and Public Health
Verified
Journal Article
Open access
Hector Pinargote-CelorioHector Pinargote-Celorio
Hector Pinargote-Celorio
IRIsabel Ribes
Isabel Ribes
SLSandra Lamrani
Sandra Lamrani
CBClaudia Boix
Claudia Boix
EAElena Algárate-Linares
Elena Algárate-Linares
EMEsperanza Merino
Esperanza Merino